PALB2 | GenomeWeb

PALB2

New Releases

Premium

Myriad Genetics' Panexia Predictive Pancreatic Cancer Test

The company is planning to develop a new diagnostic test for early detection of pancreatic cancer by combining PALB2 gene mutations with mutations in the BRCA 2 gene and p16 genes, to which Myriad also holds exclusive rights under 10 issued US patents. The test is slated for launch in 2010.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.